My top priority is to contribute to the success of exciting scientific projects, and the dissemination of impactful and accurate scientific findings. As an editorial consultant at the Max Planck Institute, I support and advise scientists through all the steps of the publication process.At Nature Communications, I handled the peer review process of clinical and translational articles. I assessed the potential impact and accuracy of innovative studies, focusing on randomized clinical trials. Outreach and liaising with opinion leaders and experts in these fields were essential parts of my job. In addition to my work as a senior editor, I was the leader of the clinical community across all Nature journals, I organized a Nature Conference in collaboration with the San Raffaele Hospital, and delivered several Nature Workshop Masterclasses.In my previous experience as a Team Manager, my priority was to motivate and support a team of scientific editors handling articles about translational and clinical Oncology. Within the company, I contributed to improving the system used to track the progression of each editor. Moreover, I was the point of contact for biostatistics and I refined our requirements regarding appropriate statistical testing.In my PhD at the Max Planck Society, I worked on multiple projects involving blood and cardiovascular development and function. Taking advantage of high-throughput genetic and pharmacological screenings, I investigated the transcriptional transition from embryonic stem cells to endothelial and hematopoietic cells, and the molecular mechanisms underlying the angiogenic process. Here, I combined CRISPR technology with bioinformatics analyses at the whole genome level using in vivo animal models using a synthetic biology approach. In addition to several publications, I designed and patented a synthetic protein with potential use in tumor angiogenesis and in age-related macular degeneration.To increase my knowledge in business, I attended the entrepreneurship summer school "Mars-42" at SISSA, which taught me how to bring science from academia to the market.